{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["20(1)"],"submitter":["Cheli Y"],"journal":["Molecular cancer"],"pagination":["21"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7839296"],"repository":["biostudies-literature"],"pubmed_title":["Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity."],"pmcid":["PMC7839296"],"pubmed_authors":["Bertolotto C","Gesson M","Tulic MK","Bille K","Strub T","Beranger GE","Montaudie H","Ballotti R","Cheli Y","Nottet N","Jacquel A","Picard-Gauci A","Close P","Passeron T","El Hachem N"],"additional_accession":[]},"is_claimable":false,"name":"Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity.","description":null,"dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Jan","modification":"2025-05-31T22:41:03.643Z","creation":"2025-05-31T22:41:03.643Z"},"accession":"S-EPMC7839296","cross_references":{"pubmed":["33504341"],"doi":["10.1186/s12943-021-01319-5"]}}